Olema Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -96.0% | +259,537.9% | -13.6% | -27.1% | +28.4% | +62.8% | +18.3% | |
| – | -96.8% | +332,071.8% | -15.0% | -28.1% | +27.6% | +64.5% | +17.6% | |
| – | -97.8% | +497,766.2% | -95.9% | +71.6% | +189.2% | +103.5% | -65.4% | |
| – | -97.8% | +497,766.2% | -15.2% | -28.8% | +28.1% | +65.8% | +16.4% | |
| – | – | – | – | +145.4% | +111.0% | +215.0% | +91.3% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +188.5% | +6,193.3% | -68.6% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +12.3% | -57.3% | +148.1% | +59.1% | +27.4% | +82.3% | +30.6% | |
| – | +585.6% | +232.7% | +96.7% | +83.5% | +30.6% | +93.1% | +24.1% | |
| – | – | – | – | +9.0% | -2.7% | +18.6% | -4.1% | |
| – | +706.0% | -23.1% | -96.8% | +1,526.1% | +621.4% | +65.3% | +107.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | -15.8% | -30.6% | +28.5% | +61.1% | +17.0% | |
| – | – | – | – | – | – | – | – | |
| – | +184.9% | -2.1% | +0.5% | +1.2% | +13.1% | +29.8% | +48.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.